Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

This study is currently recruiting participants.

Study NCT00807859 Information provided by Amgen

First Received: December 11, 2008 Last Updated: September 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2014
Estimated Primary Completion Date:	April 2013 (Final data collection date for primary outcome measure)